Results 201 to 210 of about 213,511 (352)

Opportunistic Screening for Pancreatic Cancer using Computed Tomography Imaging and Radiology Reports [PDF]

arXiv
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer, with most cases diagnosed at stage IV and a five-year overall survival rate below 5%. Early detection and prognosis modeling are crucial for improving patient outcomes and guiding early intervention strategies.
arxiv  

Targeting Mesothelin in Pancreatic Ductal Adeno- Carcinoma PDAC [PDF]

Journal of Cellular Immunology, 2020
Gilles Pagès, Christopher Montemagno
openaire   +2 more sources

Small‐Molecule KRAS Inhibitors by Tyrosine Covalent Bond Formation

ChemMedChem, Accepted Article.
The development of the KRAS G12C inhibitor sotorasib was a major advance towards drugging KRAS. However, the G12C mutation is only found in about 10% of tumors with a KRAS mutation. KRAS tyrosine amino acids could provide alternative sites for covalent drug development.
Alexander Landgraf, Robert Brenner, Mona Ghozayel, Khuchtumur Bum-Erdene, Giovanni Gonzalez-Gutierrez, Samy Meroueh   +5 more
wiley   +1 more source

Pankreaskarzinom (duktales Adenokarzinom)

Praxis, 2005
Lorenzo Käser, Vetter W, U. Kolyvanos Naumann   +2 more
openaire   +3 more sources

Delivery of Natural Small Molecules Through Nanocarriers for Cancer Treatment

Food Frontiers, EarlyView.
Natural small molecules through nanocarriers for cancer treatment ABSTRACT Cancer is a formidable adversary, accounting for the second highest number of fatalities worldwide. A multitude of studies have indicated that naturally sourced small‐molecule compounds, owing to their low toxicity and multi‐target capabilities, significantly aid in the fight ...
Fangting Ye, Shaojie Zheng, Shuo Shan, Jiaer Cai, Yufan Liu, Weichao Chen, Xinxin He, Chao Zhao   +7 more
wiley   +1 more source

Pancreatic Metastasis from Invasive Ductal Carcinoma of the Breast [PDF]

The Korean Journal of Medicine, 2017
Yunsuk Choi, Young Joo Min, Su-Jin Koh, Hee-jeong Jeon, Jin-Hee Noh, Jae-Sung Ahn, Hye-Jeong Choi   +6 more
openaire   +1 more source

Neoadjuvant chemotherapy plus anlotinib in the treatment of resectable head and neck squamous cell carcinoma: A pilot phase II trial

Cancer Communications, EarlyView.
Qianting He, Shuojin Huang, Dongxiao Tang, Congyuan Cao, Wanhang Zhou, Rongsong Ling, Jie Chen, Bokai Yun, Xin Zheng, Yanchen Li, Anxun Wang, Demeng Chen   +11 more
wiley   +1 more source

Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors

APMIS, Volume 131, Issue 2, Page 77-91, February 2023., 2023
Cytokeratin 13 (CK13) is a type I acidic low molecular weight cytokeratin, which is mainly expressed in urothelium and in the squamous epithelium of various sites of origin. Loss of CK13 has been implicated in the development and progression of squamous epithelial neoplasms. To comprehensively determine CK13 expression in normal and neoplastic tissues,
Maximilian Lennartz, Verena Sofia Ullmann, Natalia Gorbokon, Ria Uhlig, Sebastian Dwertmann Rico, Simon Kind, Viktor Reiswich, Florian Viehweger, Martina Kluth, Claudia Hube‐Magg, Christian Bernreuther, Franziska Büscheck, Devita Putri, Till S. Clauditz, Christoph Fraune, Andrea Hinsch, Frank Jacobsen, Till Krech, Patrick Lebock, Stefan Steurer, Eike Burandt, Sarah Minner, Andreas H. Marx, Ronald Simon, Guido Sauter, Anne Menz   +25 more
wiley   +1 more source

Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma

Cancer, 2012
D. Chatterjee, M. Katz, A. Rashid, G. Varadhachary, R. Wolff, Hua Wang, Jeffrey E. Lee, P. Pisters, J. Vauthey, C. Crane, H. Gomez, J. Abbruzzese, J. Fleming, Huamin Wang   +13 more
semanticscholar   +1 more source

Exosomes, autophagy, and cancer: A complex triad

International Journal of Cancer, EarlyView.
Abstract Cancer remains one of the leading causes of death worldwide. Despite remarkable progress in prevention, diagnosis, and therapy, the incidence of certain types of cancer persists, urging the identification of clinically relevant biomarkers and the development of novel therapeutic strategies to improve clinical outcomes and overcome treatment ...
María Guerra‐Andrés, Álvaro F. Fernández, Tania Fontanil   +2 more
wiley   +1 more source